AP NEWS

Influence of Artificial Intelligence on Drug Discovery & Development, 2018 - ResearchAndMarkets.com

October 1, 2018

DUBLIN--(BUSINESS WIRE)--Oct 1, 2018--The “Influence of Artificial Intelligence on Drug Discovery and Development” report has been added to ResearchAndMarkets.com’s offering.

This report outlines the impact of artificial intelligence (AI) on the global drug discovery and development landscape. Berg Health’s precision medicine platforms and a clinical overview of the company’s pipeline have been profiled in the report. Furthermore, IP trends, research aspects, and AI-medicine strategies have also been described.

Key Topics Covered

Artificial Intelligence - Overall Impact and Opportunity Leverage AI-based Precision Medicine AI-based Precision Medicine Innovation Scouting AI-driven Medicine: Approaches, Features, and Targeted Areas Clinical Trial Analysis: Bergh Health’s Pipeline Key Contacts

For more information about this report visit https://www.researchandmarkets.com/research/lc5sxv/influence_of?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181001005451/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery

KEYWORD:

INDUSTRY KEYWORD: TECHNOLOGY SOFTWARE HEALTH CLINICAL TRIALS PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/01/2018 06:53 AM/DISC: 10/01/2018 06:53 AM

http://www.businesswire.com/news/home/20181001005451/en

AP RADIO
Update hourly